Legal Representation
Attorney
Jessica Sganga
USPTO Deadlines
Next Deadline
309 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20201124)
Due Date
November 24, 2026
Grace Period Ends
May 24, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 24, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Nov 24, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 8, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 8, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 19, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 5, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 5, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 5, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 5, 2020 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 5, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 30, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 30, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 30, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 27, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 10, 2020 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jun 9, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 26, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Medical and scientific research information in the field of cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; Providing scientific information in the field of research regarding cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; Providing scientific research information in the field of clinical studies; Providing a website featuring educational information in the field of clinical research
First Use Anywhere:
May 11, 2020
First Use in Commerce:
May 11, 2020
Additional Information
Design Mark
The mark consists of the wording "ABOUTNAD" and three connected hexagons to the right of the wording.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
NICOTINAMIDE ADENINE DINUCLEOTIDE
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"NAD"